5 Key Takeaways

• 1

  Alcon's Voyager DSLT device for glaucoma is now available in the US, offering a contactless laser solution controlled via touchscreen.

• 2

  Zeiss Medical Technology's MEL 90 excimer laser received FDA approval for LASIK, allowing rapid intra-operative ablation for myopia.

• 3

  Genentech's Susvimo is the first FDA-approved treatment for diabetic macular edema that maintains vision with fewer injections.

• 4

  Norlase launched LYNX, a laser indirect ophthalmoscope with integrated pattern-scanning capabilities, enhancing retinal imaging.

• 5

  Sydnexis Inc. has a PDUFA target date for SYD-101, potentially the first pharmaceutical treatment for pediatric myopia progression in the US.